• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients.儿童肝移植受者病毒特异性 T 细胞免疫的动态变化。
Am J Transplant. 2018 Sep;18(9):2238-2249. doi: 10.1111/ajt.14967. Epub 2018 Jul 10.
2
Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.移植后活检风险:来自两项多中心免疫抑制剂撤药试验的 451 例稳定长期儿童肝移植受者经皮活检。
Am J Transplant. 2019 May;19(5):1545-1551. doi: 10.1111/ajt.15255. Epub 2019 Feb 4.
3
Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients.定量EBV病毒载量和免疫抑制改变可降低小儿肝移植受者的PTLD发病率。
Am J Transplant. 2005 Sep;5(9):2222-8. doi: 10.1111/j.1600-6143.2005.01002.x.
4
Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.肝移植后早期进行免疫抑制最小化和停药的结果。
Am J Transplant. 2019 May;19(5):1397-1409. doi: 10.1111/ajt.15205. Epub 2018 Dec 31.
5
The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study.供体病毒移植时复制对移植后受体感染的影响:一项前瞻性研究。
Transplantation. 2015 Mar;99(3):602-8. doi: 10.1097/TP.0000000000000354.
6
Successful Treatment of Kaposi Sarcoma-Associated Herpesvirus Inflammatory Cytokine Syndrome After Kidney-Liver Transplant: Correlations With the Human Herpesvirus 8 miRNome and Specific T Cell Response.肾肝联合移植后成功治疗卡波西肉瘤相关疱疹病毒炎症细胞因子综合征:与人类疱疹病毒 8 microRNA 组和特异性 T 细胞反应的相关性。
Am J Transplant. 2017 Nov;17(11):2963-2969. doi: 10.1111/ajt.14346. Epub 2017 Jun 27.
7
Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.在抢先治疗期间巨细胞病毒感染风险较高的实体器官移植受者中的病毒载量、巨细胞病毒特异性T细胞免疫反应和巨细胞病毒疾病
Transpl Int. 2014 Oct;27(10):1060-8. doi: 10.1111/tri.12378. Epub 2014 Aug 20.
8
Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.小儿肾移植术后第一年病毒血症/病毒感染、同种免疫和营养参数之间的关系
Am J Transplant. 2017 Jun;17(6):1549-1562. doi: 10.1111/ajt.14169. Epub 2017 Feb 1.
9
The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.定量爱泼斯坦-巴尔病毒聚合酶链反应及抢先性免疫抑制降低在小儿肝移植中的作用:初步经验
J Pediatr Gastroenterol Nutr. 2001 Oct;33(4):445-9. doi: 10.1097/00005176-200110000-00005.
10
CCL8 and the Immune Control of Cytomegalovirus in Organ Transplant Recipients.CCL8 与器官移植受者巨细胞病毒的免疫控制。
Am J Transplant. 2015 Jul;15(7):1882-92. doi: 10.1111/ajt.13207. Epub 2015 Mar 12.

引用本文的文献

1
The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation.《实体器官移植中巨细胞病毒管理的第四届国际共识指南》
Transplantation. 2025 Jul 1;109(7):1066-1110. doi: 10.1097/TP.0000000000005374. Epub 2025 Apr 9.
2
Epstein-Barr virus-specific T-cell response in pediatric liver transplant recipients: a cross-sectional study by multiparametric flow cytometry.采用多参数流式细胞术检测儿童肝移植受者中 EBV 特异性 T 细胞反应:一项横断面研究。
Front Immunol. 2024 Oct 24;15:1479472. doi: 10.3389/fimmu.2024.1479472. eCollection 2024.
3
Use of Specific T Lymphocytes in Treating Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients: A Systematic Review.特定T淋巴细胞在造血细胞移植受者巨细胞病毒感染治疗中的应用:一项系统评价
Pharmaceutics. 2024 Oct 11;16(10):1321. doi: 10.3390/pharmaceutics16101321.
4
Comparison of Different Blood Transfusion Methods in Patients Undergoing Cesarean Section.剖宫产患者不同输血方法的比较
Front Surg. 2022 Feb 22;9:844984. doi: 10.3389/fsurg.2022.844984. eCollection 2022.
5
Virus-specific T cells in pediatric renal transplantation.儿科肾移植中的病毒特异性 T 细胞。
Pediatr Nephrol. 2021 Apr;36(4):789-796. doi: 10.1007/s00467-020-04522-6. Epub 2020 Mar 27.

本文引用的文献

1
Epstein-Barr virus lymphoproliferative disease after solid organ transplantation.实体器官移植后爱泼斯坦-巴尔病毒淋巴增殖性疾病
Cytotherapy. 2017 Nov;19(11):1270-1283. doi: 10.1016/j.jcyt.2017.08.010. Epub 2017 Sep 29.
2
Overview of Immunosuppressive Therapy in Solid Organ Transplantation.实体器官移植中的免疫抑制治疗概述
Anesthesiol Clin. 2017 Sep;35(3):365-380. doi: 10.1016/j.anclin.2017.04.001.
3
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.现成的病毒特异性T细胞用于治疗异基因造血干细胞移植后的BK病毒、人类疱疹病毒6型、巨细胞病毒、爱泼斯坦-巴尔病毒和腺病毒感染。
J Clin Oncol. 2017 Nov 1;35(31):3547-3557. doi: 10.1200/JCO.2017.73.0655. Epub 2017 Aug 7.
4
CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy.巨细胞病毒特异性 T 细胞免疫在实体器官移植受者中处于低巨细胞病毒感染风险。时间顺序和在抢先治疗中的适用性。
J Infect. 2017 Oct;75(4):336-345. doi: 10.1016/j.jinf.2017.05.020. Epub 2017 Jun 13.
5
An Interventional Study Using Cell-Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation.一种利用细胞介导免疫的移植后巨细胞病毒感染个体化治疗的介入研究。
Am J Transplant. 2017 Sep;17(9):2468-2473. doi: 10.1111/ajt.14347. Epub 2017 Jun 16.
6
BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study.BK 多瘤病毒特异性 9 mer CD8 T 细胞反应与肾移植受者 BK 病毒血症清除相关:来自瑞士移植队列研究的首次报告。
Am J Transplant. 2017 Oct;17(10):2591-2600. doi: 10.1111/ajt.14282. Epub 2017 Apr 25.
7
Infection in Organ Transplantation.器官移植中的感染
Am J Transplant. 2017 Apr;17(4):856-879. doi: 10.1111/ajt.14208. Epub 2017 Mar 10.
8
Virus-specific T-cell therapy in solid organ transplantation.
Transpl Int. 2016 May;29(5):515-26. doi: 10.1111/tri.12659. Epub 2015 Sep 9.
9
Survival benefit of solid-organ transplant in the United States.美国实体器官移植的生存获益。
JAMA Surg. 2015 Mar 1;150(3):252-9. doi: 10.1001/jamasurg.2014.2038.
10
Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation.实体器官移植中预测感染风险的临床免疫监测策略。
Clin Transl Immunology. 2014 Feb 28;3(2):e12. doi: 10.1038/cti.2014.3. eCollection 2014 Feb.

儿童肝移植受者病毒特异性 T 细胞免疫的动态变化。

Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients.

机构信息

Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA.

Department of Pediatric Hematology/Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.

出版信息

Am J Transplant. 2018 Sep;18(9):2238-2249. doi: 10.1111/ajt.14967. Epub 2018 Jul 10.

DOI:10.1111/ajt.14967
PMID:29900673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6117219/
Abstract

Immunosuppression following solid organ transplantation (SOT) has a deleterious effect on cellular immunity leading to frequent and prolonged viral infections. To better understand the relationship between posttransplant immunosuppression and circulating virus-specific T cells, we prospectively monitored the frequency and function of T cells directed to a range of latent (CMV, EBV, HHV6, BK) and lytic (AdV) viruses in 16 children undergoing liver transplantation for up to 1 year posttransplant. Following transplant, there was an immediate decline in circulating virus-specific T cells, which recovered posttransplant, coincident with the introduction and subsequent routine tapering of immunosuppression. Furthermore, 12 of 14 infections/reactivations that occurred posttransplant were successfully controlled with immunosuppression reduction (and/or antiviral use) and in all cases we detected a temporal increase in the circulating frequency of virus-specific T cells directed against the infecting virus, which was absent in 2 cases where infections remained uncontrolled by the end of follow-up. Our study illustrates the dynamic changes in virus-specific T cells that occur in children following liver transplantation, driven both by active viral replication and modulation of immunosuppression.

摘要

实体器官移植(SOT)后的免疫抑制对细胞免疫有有害影响,导致频繁和长期的病毒感染。为了更好地了解移植后免疫抑制与循环病毒特异性 T 细胞之间的关系,我们前瞻性地监测了 16 名接受肝移植的儿童在移植后长达 1 年的时间内针对一系列潜伏(CMV、EBV、HHV6、BK)和裂解(AdV)病毒的 T 细胞的频率和功能。移植后,循环病毒特异性 T 细胞立即下降,在移植后恢复,与免疫抑制的引入和随后的常规逐渐减少同步。此外,移植后发生的 14 次感染/再激活中的 12 次通过减少免疫抑制(和/或使用抗病毒药物)成功得到控制,在所有情况下,我们都检测到针对感染病毒的循环病毒特异性 T 细胞的频率出现暂时增加,而在 2 例感染在随访结束时仍未得到控制的情况下则没有这种情况。我们的研究说明了儿童肝移植后病毒特异性 T 细胞的动态变化,这是由病毒的主动复制和免疫抑制的调节共同驱动的。